表紙
市場調查報告書
商品編碼
1023287

臨床試驗用品的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):臨床階段 (階段I·II·III)·產品&服務·終端用戶·治療用途·各地區

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Service, By End-use, By Therapeutic Use, By Region, And Segment Forecasts, 2021 - 2028

出版日期: | 出版商: Grand View Research, Inc. | 英文 123 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球臨床試驗用品的市場規模在預測期間內預計將以6.0%的年複合成長率推移,到2028年成長到29億美元的規模。

臨床試驗的增加,更複雜的臨床試驗、區域擴張以及促進更大程度整合和更順暢活動的 IT 發展等因素正在推動市場增長。

本報告提供全球臨床試驗用品的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的轉變·預測,臨床階段·產品&服務·終端用戶·治療用途·地區/主要國家等各種區分的明細,競爭環境,市場佔有率,主要企業簡介等資訊。

第1章 調查手法·調查範圍

第2章 摘要整理

第3章 市場可變因素·趨勢·展望

  • 市場動態

第4章 市場分析·預測:各臨床階段

  • 階段I
  • 階段II
  • 階段III
  • 其他

第5章 市場分析·預測:產品·各類服務

  • 製造
  • 保管·流通
  • 供應鏈管理

第6章 市場分析·預測:各終端用戶

  • 製藥
  • 生技藥品
  • 醫療設備
  • 其他

第7章 市場分析·預測:各治療用途

  • 腫瘤
  • 中樞神經系統(CNS)障礙
  • 心血管
  • 感染疾病
  • 代謝障礙
  • 其他

第8章 市場分析·預測:地區·各主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第9章 競爭分析

  • 企業簡介
    • Almac Group
    • Biocair
    • Catalent, Inc.
    • KLIFO
    • Movianto (Walden Group)
    • PCI Pharma Services
    • Sharp
    • Thermo Fischer Scientific, Inc.
    • Marken
    • Parexel International Corporation
目錄
Product Code: GVR-1-68038-514-4

Clinical Trial Supplies Market Growth & Trends:

The global clinical trial supplies market is expected to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 6.0% CAGR owing to the Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are the primary driver of the industry. Furthermore, geographic expansion and development of Information Technology (IT) to facilitate higher integration and smooth performance of activities are other vitally impacting parameters. Over the next eight years, the clinical trials and pharmaceutical industry is anticipated to continue steady growth, thereby promoting the high requirement of clinical trial supplies.

U.S and Canada are home to majority of clinical trials which are conducted in this region. No language barrier is one of the major factors for the preference of this region for majority of clinical trials, as English language is widely spoken in this region. Major CRO's and biopharmaceutical companies have their hub in this region and with advancement in technology the demand for efficient supplies is increasing and the region is expected to dominate the clinical trial supplies market over the forecast period.

Clinical Trial Supplies Market Report Highlights:

  • On the basis of clinical phase, the market is anticipated to be dominated by Phase III in 2025. The presence of large number of molecules estimated to reach Phase III by 2020 is the primary factor responsible for this prediction.
  • By services, storage and distribution is anticipated to witness the fastest growth at a CAGR of over 7.0%.
  • Key end-users of this industry are pharmaceuticals, and biologics. Biologics are expected to witness fastest growth owing to the increasing research in the field of genetics and biotechnology such as development of nanoparticle-based drug delivery systems.
  • In terms of therapeutic use or clinical indication, oncology dominates the market. The highest research activity as of 2016 is being performed for this indication, which in turn is expected to drive the market.
  • Few of the industry players include Movianto GmbH, Thermo Fischer Scientific, Sharp Packaging Services, Catalent Pharma Solution, Biocair International Ltd., PCI Services, Almac Group Ltd, and Patheon Inc. Other players present in the market space include Clinigen Group Plc, Merck Serono, and Chimerix.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Phase
    • 1.1.2 Product and Service
    • 1.1.3 End-use
    • 1.1.4 Therapeutic Use
    • 1.1.5 Regional Scope
    • 1.1.6 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for Primary Interviews in Europe
      • 1.3.5.3 Data for Primary Interviews in APAC
      • 1.3.5.4 Data for Primary Interviews in Latin America
      • 1.3.5.5 Data for Primary Interviews in MEA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective 1:
    • 1.8.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Clinical Trial Supplies Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Expansion of clinical trial sites
      • 3.1.1.2 Growing R&D in biologics and biosimilars
      • 3.1.1.3 Advancements in supply chain technology
      • 3.1.1.4 Increase in comparator sourcing
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Presence of stringent regulatory policies
      • 3.1.2.2 High possibility of counterfeiting of drugs
    • 3.1.3 Penetration & Growth Prospect Mapping
    • 3.1.4 SWOT Analysis by PESTEL
    • 3.1.5 Industry Analysis-Porter's
    • 3.1.6 Clinical Trial Supplies Market: Impact of COVID-19
      • 3.1.6.1 Supply Chain
      • 3.1.6.2 Changing Market Trends

Chapter 4 Clinical Trial Supplies Market: Segment Analysis, By Clinical Phase, 2016 - 2028 (USD Million)

  • 4.1 Definitions and Scope
  • 4.2 Phase Market Share Analysis
  • 4.3 Segment Dashboard
  • 4.4 Clinical trial supplies Market by Phase
    • 4.4.1 Phase I
      • 4.4.1.1 Phase I market estimates and forecast, 2016 - 2028 (in million)
    • 4.4.2 Phase II
      • 4.4.2.1 PHASE II market estimates and forecast, 2016 - 2028 (in million)
    • 4.4.3 Phase III
      • 4.4.3.1 PHASE III market estimates and forecast, 2016 - 2028 (in million)
    • 4.4.4 Others
      • 4.4.4.1 Others market estimates and forecast, 2016 - 2028 (in million)

Chapter 5 Clinical Trial Supplies Market: Segment Analysis, By Product and Service, 2016 - 2028 (USD Million)

  • 5.1 Definitions and Scope
  • 5.2 Product and Service Market Share Analysis
  • 5.3 Segment Dashboard
  • 5.4 Clinical Trial Supplies Market by Product/Service
    • 5.4.1 Manufacturing
      • 5.4.1.1 Manufacturing market estimates and forecast, 2016 - 2028 (in Million)
    • 5.4.2 Storage & Distribution
      • 5.4.2.1 Storage & distribution market estimates and forecast, 2016 - 2028 (in Million)
      • 5.4.2.1.1 Cold Chain Distribution
      • 5.4.2.1.2 Non-Cold Chain Distribution
    • 5.4.3 Supply Chain Management
      • 5.4.3.1 Supply chain management market estimates and forecast, 2016 - 2028 (in Million)

Chapter 6 Clinical Trial Supplies Market: Segment Analysis, By End Use, 2016 - 2028 (USD Million)

  • 6.1 Definitions and Scope
  • 6.2 End Use Market Share Analysis
  • 6.3 Segment Dashboard
  • 6.4 Clinical Trial Supplies Market By End Use
    • 6.4.1 Pharmaceutical
      • 6.4.1.1 Pharmaceutical market estimates and forecast, 2016 - 2028 (in Million)
    • 6.4.2 Biologics
      • 6.4.2.1 Biologics market estimates and forecast, 2016 - 2028 (in Million)
    • 6.4.3 Medical Devices
      • 6.4.3.1 Medical devices market estimates and forecast, 2016 - 2028 (in Million)
    • 6.4.4 Others
      • 6.4.4.1 Others market estimates and forecast, 2016 - 2028 (in Million)

Chapter 7 Clinical Trial Supplies Market: Segment Analysis, By Therapeutic Use, 2016 - 2028 (USD Million)

  • 7.1 Definitions and Scope
  • 7.2 Therapeutic Use Market Share Analysis
  • 7.3 Segment Dashboard
  • 7.4 Clinical Trial Supplies Market by Therapeutic Use
    • 7.4.1 Oncology
      • 7.4.1.1 Oncology market estimates and forecast, 2016 - 2028 (in Million)
    • 7.4.2 Central Nervous System (CNS) Disorders
      • 7.4.2.1 CNS market estimates and forecast, 2016 - 2028 (in Million)
    • 7.4.3 Cardiovascular
      • 7.4.3.1 Cardiovascular market estimates and forecast, 2016 - 2028 (in Million)
    • 7.4.4 Infectious diseases
      • 7.4.4.1 Infectious diseases market estimates and forecast, 2016 - 2028 (in Million)
    • 7.4.5 Metabolic disorders
      • 7.4.5.1 Metabolic disorders market estimates and forecast, 2016 - 2028 (in Million)
    • 7.4.6 Others
      • 7.4.6.1 Others market estimates and forecast, 2016 - 2028 (in Million)

Chapter 8 Clinical Trial Supplies Market: Regional Market Analysis, 2016 - 2028 (USD Million)

  • 8.1 Regional Market Dashboard
  • 8.2 Definitions and Scope
  • 8.3 Regional Market Share Analysis
  • 8.4 North America
    • 8.4.1 North America Market estimates and forecast, 2016 - 2028
    • 8.4.2 U.S.
      • 8.4.2.1 U.S. market estimates and forecast, 2016 - 2028
    • 8.4.3 Canada
      • 8.4.3.1 Canada market estimates and forecast, 2016 - 2028
  • 8.5 Europe
    • 8.5.1 Europe market estimates and forecast, 2016 - 2028
    • 8.5.2 Germany
      • 8.5.2.1 Germany market estimates and forecast, 2016 - 2028
    • 8.5.3 U.K.
      • 8.5.3.1 U.K. market estimates and forecast, 2016 - 2028
  • 8.6 Asia Pacific
    • 8.6.1 Asia Pacific market estimates and forecast, 2016 - 2028
    • 8.6.2 China
      • 8.6.2.1 China Market estimates and forecast, 2016 - 2028
    • 8.6.3 Japan
      • 8.6.3.1 Japan market estimates and forecast, 2016 - 2028
  • 8.7 Latin America
    • 8.7.1 Latin America market estimates and forecast, 2016 - 2028
    • 8.7.2 Brazil
      • 8.7.2.1 Brazil market estimates and forecast, 2016 - 2028
    • 8.7.3 Mexico
      • 8.7.3.1 Mexico Market estimates and forecast, 2016 - 2028
  • 8.8 Middle East and Africa
    • 8.8.1 Middle East And Africa Market estimates and forecast, 2016 - 2028
    • 8.8.2 South Africa
      • 8.8.2.1 South Africa market estimates and forecast, 2016 - 2028
    • 8.8.3 Saudi Arabia
      • 8.8.3.1 Saudi Arabia market estimates and forecast, 2016 - 2028

Chapter 9 Clinical Trial Supplies Market - Competitive Analysis

  • 9.1 Company Profiles
    • 9.1.1 Almac Group
      • 9.1.1.1 Company overview
      • 9.1.1.2 Service benchmarking
      • 9.1.1.3 Strategic initiatives
    • 9.1.2 Biocair
      • 9.1.2.1 Company overview
      • 9.1.2.2 Service benchmarking
      • 9.1.2.3 Strategic initiatives
    • 9.1.3 Catalent, Inc.
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 ServIce benchmarking
      • 9.1.3.4 Strategic initiatives
    • 9.1.4 KLIFO
      • 9.1.4.1 Company overview
      • 9.1.4.2 Service benchmarking
      • 9.1.4.3 Strategic initiatives
    • 9.1.5 Movianto (Walden Group)
      • 9.1.5.1 Company overview
      • 9.1.5.2 Service benchmarking
      • 9.1.5.3 Strategic initiatives
    • 9.1.6 PCI Pharma Services
      • 9.1.6.1 Company overview
      • 9.1.6.2 Service benchmarking
      • 9.1.6.3 Strategic initiatives
    • 9.1.7 Sharp
      • 9.1.7.1 Company overview
      • 9.1.7.2 Service benchmarking
      • 9.1.7.3 Strategic initiatives
    • 9.1.8 Thermo Fischer Scientific, Inc.
      • 9.1.8.1 Company overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Service benchmarking
      • 9.1.8.4 Strategic initiatives
    • 9.1.9 Marken
      • 9.1.9.1 Company overview
      • 9.1.9.2 Service benchmarking
      • 9.1.9.3 Strategic initiatives
    • 9.1.10 Parexel International Corporation
      • 9.1.10.1 Company Overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Service Benchmarking
      • 9.1.10.4 Strategic Initiatives

List of Tables

  • 1. North America clinical trials supplies market, by clinical phases, 2016 - 2028 (USD Million)
  • 2. North America clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 3. North America clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 4. North America clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 5. North America clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 6. U.S. clinical trials supplies market, by clinical phases, 2016 - 2028 (USD Million)
  • 7. U.S. clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 8. U.S. clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 9. U.S. clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 10. U.S. clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 11. Canada clinical trials supplies market, by clinical phases, 2016 - 2028 (USD Million)
  • 12. Canada clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 13. Canada clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 14. Canada clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 15. Canada clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 16. Europe clinical trials supplies market, by clinical phases, 2016 - 2028 (USD Million)
  • 17. Europe clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 18. Europe clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 19. Europe clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 20. Europe clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 21. U.K. clinical trials supplies market, by clinical phases, 2016 - 2028 (USD Million)
  • 22. U.K. clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 23. U.K. clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 24. U.K. clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 25. U.K. clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 26. Germany clinical trials supplies market, by clinical phases, 2016 - 2028 (USD Million)
  • 27. Germany clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 28. Germany clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 29. Germany clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 30. Germany clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 31. Germany clinical trials supplies market, by clinical phases, 2016 - 2028 (USD Million)
  • 32. Asia Pacific clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 33. Asia Pacific clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 34. Asia Pacific clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 35. Asia Pacific clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 36. Asia Pacific clinical trials supplies market, by clinical phases, 2016 - 2028 (USD Million)
  • 37. Japan clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 38. Japan clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 39. Japan clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 40. Japan clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 41. China clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 42. China clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 43. China clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 44. China clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 45. Latin America clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 46. Latin America clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 47. Latin America clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 48. Latin America clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 49. Brazil clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 50. Brazil clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 51. Brazil clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 52. Brazil clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 53. Mexico clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 54. Mexico clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 55. Mexico clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 56. Mexico clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 57. MEA clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 58. MEA clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 59. MEA clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 60. MEA clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 61. South Africa clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 62. South Africa clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 63. South Africa clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 64. South Africa clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)
  • 65. Saudi Arabia clinical trials supplies market, by product and services, 2016 - 2028 (USD Million)
  • 66. Saudi Arabia clinical trials supplies storage and distribution market, by type, 2016 - 2028 (USD Million)
  • 67. Saudi Arabia clinical trials supplies market, by end use, 2016 - 2028 (USD Million)
  • 68. Saudi Arabia clinical trials supplies market, by therapeutics use, 2016 - 2028 (USD Million)

List of Figures

  • 1. Market research process
  • 2. Information procurement
  • 3. Primary research pattern
  • 4. Market research approaches
  • 5. Value chain based sizing & forecasting
  • 6. QFD modeling for market share assessment
  • 7. Market summary (Figures in USD Million, 2016)
  • 8. Market trends & outlook
  • 9. Clinical trial supplies market: Market segmentation
  • 10. Clinical trial supplies market revenue, (USD Million), 2016 - 2028
  • 11. Key Opportunities Prioritized
  • 12. Clinical trial supplies: Porter's analysis
  • 13. Clinical trial supplies: PESTEL analysis
  • 14. Clinical trial supplies market: Clinical phase outlook key takeaways
  • 15. Clinical trial supplies market: Clinical phase movement analysis
  • 16. Phase I market, 2016 - 2028 (USD Million)
  • 17. Phase II market, 2016 - 2028 (USD Million)
  • 18. Phase III market, 2016 - 2028 (USD Million)
  • 19. Others market, 2016 - 2028 (USD Million)
  • 20. Clinical trial supplies market product & service outlook key takeaways
  • 21. Clinical trial supplies market: Product & Service movement analysis
  • 22. Manufacturing market, 2016 - 2028 (USD Million)
  • 23. Storage & distribution market, 2016 - 2028 (USD Million)
  • 24. Cold chain-based storage & distribution market, 2016 - 2028 (USD Million)
  • 25. Non-cold chain-based storage & distribution market, 2016 - 2028 (USD Million)
  • 26. Supply chain management market, 2016 - 2028 (USD Million)
  • 27. Clinical trial supplies market end-use outlook key takeaways
  • 28. Clinical trial supplies market: End-use movement analysis
  • 29. Pharmaceuticals market, 2016 - 2028 (USD Million)
  • 30. Biologics market, 2016 - 2028 (USD Million)
  • 31. Medical device market, 2016 - 2028 (USD Million)
  • 32. Other end-use market, 2016 - 2028 (USD Million)
  • 33. Clinical trial supplies market therapeutic use outlook key takeaways
  • 34. Clinical trial supplies market: Therapeutic use movement analysis
  • 35. Oncology market, 2016 - 2028 (USD Million)
  • 36. CNS disorders market, 2016 - 2028 (USD Million)
  • 37. Cardiovascular market, 2016 - 2028 (USD Million)
  • 38. Infectious disease market, 2016 - 2028 (USD Million)
  • 39. Metabolic disorders market, 2016 - 2028 (USD Million)
  • 40. Other therapeutic use market, 2016 - 2028 (USD Million)
  • 41. Regional market-place: Key takeaways
  • 42. North America clinical trial supplies market, 2013 - 2024 (USD Million)
  • 43. U.S. clinical trial supplies market, 2016 - 2028 (USD Million)
  • 44. Canada clinical trial supplies market, 2016 - 2028 (USD Million)
  • 45. Europe clinical trial supplies market, 2016 - 2028 (USD Million)
  • 46. U.K. clinical trial supplies market, 2016 - 2028 (USD Million)
  • 47. Germany clinical trial supplies market, 2016 - 2028 (USD Million)
  • 48. Asia Pacific clinical trial supplies market, 2016 - 2028 (USD Million)
  • 49. Japan clinical trial supplies market, 2016 - 2028 (USD Million)
  • 50. China clinical trial supplies market, 2016 - 2028 (USD Million)
  • 51. Latin America clinical trial supplies market, 2016 - 2028 (USD Million)
  • 52. Brazil clinical trial supplies market, 2016 - 2028 (USD Million)
  • 53. Mexico clinical trial supplies market, 2016 - 2028 (USD Million)
  • 54. MEA clinical trial supplies market, 2016 - 2028 (USD Million)
  • 55. South Africa clinical trial supplies market, 2016 - 2028 (USD Million)
  • 56. Saudi Arabia clinical trial supplies market, 2016 - 2028 (USD Million)